button

range

Verona Pharma plc American Depositary

Dare Bioscience Inc

investor

let me post some silly articles that have zero to do with raising capital or selling products and pretend its good for the investor.

All the while ignoring investors and failing to meet EVERY goal SHE sets for herself and our company!!

With supply chain issues coupled with staffing (VISA problems), COVID resurgence, ARS and Influenza, he is leading   investors up a gangway to a sinking ship.

Market cap does not make sense, its inflated beyond any reasonable bio investors expectations.

I finally, reluctantly accept that this stock won’t do what many investors believed for so long.

Do they truly not care about their investors or stock?

The kiddos pushing this garbage are some of objectively the WORST investors out there.

$DARE  
 
heres an example of how scummy they are to investors.

game

He is just playing games with people’s money.

You are the worst dude, you intentionally scam a ton of people into this crap, I&#39;m straight up honest about what I am doing here, my games not hurting novice retail, look in the mirror.

but I am tired of the games being played with this stock.

Sick life that boy leads and it&#39;s hard to understand what his game is.

deal

No products, lousy deals with manufacturing drug companies,delayed trials, etc.

Dare made a lousy deal cause it’s a lousy deal or none at all.

So that should be a major warning sign along with the fact Bayer didn’t pony up to lock in the deal and provide dare the desperately needed funding.

Without seeing any inventory payments to date, it could be a supply chain issue causing the deal.

Hell don’t even know details of there “deal”.

application

$DARE ONE YEAR since FDA drug approval, and Co+Shares keep on sinking into the abyss.

$DARE One year since FDA approval, and SP keep on marching backwards.

No company with an FDA approved product about to start sales in a quarter should be this low.

$DARE  so all 2022 with FDA approval for a product and no production until mid 2023 if they don&#39;t miss another deadline, shocking incompetence.

11 months since first fda approval and still nothing on the shelf.

$DARE Down almost 50% YTD…..after FDA approval and commercialization details…

Hot garbage.

board Members also sit on boards of companies dare has licensing/lab agreements with(smells bad) 
 
xaciato may be the worst and most inefficient rollout for a non revenue generating companies first fda approval.

approval

$DARE straight down hill since approved mismanaged garbage company.

INSANE CASH BURN and about to get dramatically worse, DRAMATICALLY 
9 studies that they will have to pay for, not to get approved, just to get to the next step.

$PRVB  
same happened at $BLUE  $CHRS $DARE and $NVAX upon approval major price suppression by MMs fuck them we need to revolt! !

company

However, this company just seems like it has a lot of potential.

Price is gonna be what it is right now,  it doesn’t change the fact this is a great company.

He’s still touting how great Sabrina and this company are.

yep perfect sense for a company woth zero revenue, and zero phase 3 products…see how this works?

And support this company to lean and good times.

Airfare, hotels, cars, event set, space rental, all in all who cares, its just cash burn, they are good at cash burn, actually come to think of it, cash burn is what this company excels at, they can light money on fire like no bio on the market.

like i always say…real companies say time is money…here they say time is shareholder money.

Sabrina and company doing great things in women’s health at Dare!! !…

With letter of compliance on its way, XACIATO sales in the not so far horizon and the pipeline registering success over success through out the year, this company won’t be a small cap biotech/pharmaceutical company no more.

This is a real company, that&#39;s making real progress in becoming a player in the women&#39;s health space.

bullish

$DARE bullish bullish and bullish 🚀🚀🚀

$DARE  bullish bullish and bullish 🚀🚀🚀

$DARE bullish bullish and bullish very  bullish 🚀🚀🚀

$DARE Momentum indicators are so freaking bullish.

$DARE Shit…..I’m not mad, I doubled my position from 1.00 down to .82, lowered my average, and still have over 19k shares…….IM JUST BULLISH AF!!!! !

news

$DARE 
Good news today for those of us grounded in reality

but should be a pop in biotech with Lily earnings news being good.

Funny how all bearish comments cease to exist after this amazing news.

but good news came in 2022 for this little engine that could.

$DARE Up 47% with No news so imaging if there was any news what would happen 🤮🤮🤮🤮🤮🤮🤮🤮🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀
Come on bro and get some @Pacho_Unlimited

$DARE nice to see the volume on the good news!

but good news the past year, bulls we still here.

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

Let’s go into February trading the $14-$15 range. Make it real interesting for the shorts :)

Australia alone can catapult this share price into the hundred dollar+ range.

$AVXL wow unbelievable.. I’ll renter around 5-6 dollar range..

business-result

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

drug

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

trial

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

$AVXL Australia trial data meets the gold standard.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

Top Stocks matching your search for "button range"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

VRNA

Verona Pharma plc American Depositary

-11.52%

$22.05 - $19.51

Dec, 23, 2022

DARE

Dare Bioscience Inc

-16.67%

$1.20 - $1.00

Nov, 5, 2022

Oct, 13, 2022

Divihomes is Now Live

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Mar, 21, 2023

VRNA

Verona Pharma plc American Depositary

-11.52%

$22.05 - $19.51

DARE

Dare Bioscience Inc

-16.67%

$1.20 - $1.00

Nov, 5, 2022

Oct, 13, 2022

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Mar, 21, 2023